SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chains, announced today Today the Company’s Chief Financial Officer and Chief Information Officer, Todd Morrow, has been promoted and will now serve as the Company’s President.
Prior to joining the company, Morrow, who has over 20 years of experience in product development, merchandising and marketing, served as Vice President of Merchandising and Merchandise Planning and Allocation for Santa Monica-based Independent Pet Partners Holdings, LLC. He has also held senior positions at Petco Animal Supplies and Pirch, a luxury home appliance and plumbing retailer.
Morrow has been with the company since 2018 and has held various leadership positions such as president of the company’s subsidiary HempMeds®, chief information officer and chief financial and information officer. While in his most recent role, Morrow gained valuable experience working with the company’s leadership team to support Medical Marijuana, Inc.’s global expansion, planning and performance. , he will increase his contributions and lead the company’s global operations.
“Todd has been an integral part of our team over the years,” said Medical Marijuana, Inc. CEO Blake Schroeder. “I am confident that he will continue to excel in the planning and financial aspects of our business, and he will now also ensure that we are able to execute those plans to a high standard.”
“As the industry embarks on another wave of significant legislative victories, I couldn’t be more excited to take on this expanded leadership role,” said Medical Marijuana, Inc. President Todd Morrow. “Our portfolio of companies will continue to find new ways to be industry leaders in manufacturing, R&D and retail and will help provide access to high-quality cannabis products for people. of the whole world. I look forward to focusing on establishing and growing our operations around the world and driving the industry forward.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct non-psychoactive cannabinoid business units: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in providing the highest quality non-psychoactive legal cannabis products derived from industrial hemp; and a clinical research and development sector for cannabinoid-based botanical drugs led by its pharmaceutical investment companies and partners, including AXIM® Biotechnologies, Inc.. and Neuropathix. Medical Marijuana, Inc. was named one of the top CBD producers by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship product Genuine Scientific Hemp Oil has been used in several successful clinical studies in Mexico and Brazil to understand its safety and effectiveness.
Medical Marijuana, Inc. is headquartered in San Diego, CA and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To view the Medical Marijuana, Inc. corporate video, Click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by these articles. This document contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ materially from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Medical Marijuana, Inc. does not sell or distribute products that violate the US Controlled Substances Act.
Contact with Investor Relations:
T. (858) 283-4016
#Medical #Marijuana #Promotes #Chief #Financial #Information #Officer #Todd #Morrow #Company #President